VAERS Explorer
Back to explore

Report #2832488

Received Mar 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
6 yrs
State
AR
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

6 year old was administered flublok with no reported adverse event; Initial information received on 19-Mar-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 6 years old male patient who was administered with Influenza Trivalent Recombinant Vaccine [Flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Trivalent Recombinant Vaccine, Solution for injection, (unknown strength and expiry date) lot number not reported via unknown route in unknown administration site for Immunisation with no reported adverse events (Inappropriate age at vaccine administration) (Latency same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Reportedly, She asked if the patient would get the regular Fluzone next season. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.